Abstract A159: The inherent resistant of breast cancer to EGFR-targeted therapies is driven by EMT-induced expression of particular FGFR splice variants.
Year: 2013
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institutions: Case Western Reserve University, Cleveland Clinic
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2049242891